This inventor holds 1 USPTO granted patent. Top assignee: Nanjing Umab-Biopharma Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Dong Ding - Innovator in Biopharmaceuticals
Introduction
Dong Ding is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative treatments for tumors and viral infections. His work is characterized by a strong focus on fusion proteins and their applications in medicine.
Latest Patents
Dong Ding holds 1 patent for a fusion protein and its application in preparing medicine for treating tumors and/or viral infections. The patent describes a fusion protein that includes an antibody or antigen-binding fragment that specifically binds to human OX40 and a human interferon. This innovative approach aims to enhance the efficacy of pharmaceutical compositions in treating serious health conditions.
Career Highlights
Dong Ding is associated with Nanjing Umab-biopharma Co., Ltd., where he continues to advance his research and development efforts. His work at the company reflects his commitment to improving therapeutic options for patients suffering from complex diseases.
Collaborations
Dong Ding collaborates with notable colleagues, including Shifu Mo and Yong Zhao. Their combined expertise contributes to the innovative environment at Nanjing Umab-biopharma Co., Ltd.
Conclusion
Dong Ding's contributions to the field of biopharmaceuticals highlight his role as an inventor dedicated to advancing medical science. His innovative work in fusion proteins represents a significant step forward in the treatment of tumors and viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile